BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26277021)

  • 21. In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201.
    Huerta S; Gao X; Livingston EH; Kapur P; Sun H; Anthony T
    Surgery; 2010 Aug; 148(2):346-53. PubMed ID: 20633731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
    Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis.
    Kim HK; Lee I; Kim ST; Lee J; Kim KM; Park JO; Kang WK
    Sci Rep; 2019 Dec; 9(1):19439. PubMed ID: 31857616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.
    Kinzel L; Ernst A; Orth M; Albrecht V; Hennel R; Brix N; Frey B; Gaipl US; Zuchtriegel G; Reichel CA; Blutke A; Schilling D; Multhoff G; Li M; Niyazi M; Friedl AA; Winssinger N; Belka C; Lauber K
    Oncotarget; 2016 Jul; 7(28):43199-43219. PubMed ID: 27259245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
    Hamano S; Mori Y; Aoyama M; Kataoka H; Tanaka M; Ebi M; Kubota E; Mizoshita T; Tanida S; Johnston RN; Asai K; Joh T
    Cancer Lett; 2015 Jan; 356(2 Pt B):846-54. PubMed ID: 25444894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
    Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthermia synergizes with tissue factor knockdown to suppress the growth and hepatic metastasis of colorectal cancer in orthotopic tumor model.
    Li H; Tian ML; Yu G; Liu YC; Wang X; Zhang J; Ji SQ; Zhu J; Wan YL; Tang JQ
    J Surg Oncol; 2012 Nov; 106(6):689-95. PubMed ID: 22532129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: an experimental study with human gastric cancer cells and mice].
    Wang BH; Qian W; Gao YJ; Wang HF; Hou XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):266-71. PubMed ID: 16677508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.
    Kaneko N; Miura K; Gu Z; Karasawa H; Ohnuma S; Sasaki H; Tsukamoto N; Yokoyama S; Yamamura A; Nagase H; Shibata C; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1235-40. PubMed ID: 19878654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells.
    Shelton JW; Waxweiler TV; Landry J; Gao H; Xu Y; Wang L; El-Rayes B; Shu HK
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):469-76. PubMed ID: 23540347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity.
    Li MY; Zhu M; Feng F; Cai FY; Fan KC; Jiang H; Wang ZQ; Linghu EQ
    Genet Mol Res; 2014 Apr; 13(3):6981-94. PubMed ID: 24782214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitizer Effect of β-Apopicropodophyllin against Colorectal Cancer via Induction of Reactive Oxygen Species and Apoptosis.
    Kwon JH; Lee NG; Kang AR; Song JY; Hwang SG; Um HD; Kim J; Park JK
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
    Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
    Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
    Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo.
    Yin A; Jiang Y; Zhang X; Zhao J; Luo H
    Eur J Pharmacol; 2010 Dec; 649(1-3):120-6. PubMed ID: 20869960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTOR signaling pathway is a target for the treatment of colorectal cancer.
    Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
    Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.
    Troiani T; Napolitano S; Vitagliano D; Morgillo F; Capasso A; Sforza V; Nappi A; Ciardiello D; Ciardiello F; Martinelli E
    Clin Cancer Res; 2014 Jul; 20(14):3775-86. PubMed ID: 24812410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.